Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan.
Liver Int. 2011 Mar;31(3):417-24. doi: 10.1111/j.1478-3231.2010.02447.x. Epub 2011 Jan 14.
Spontaneous bacterial empyema (SBE) is a complication of cirrhotic patients in which a pre-existing pleural effusion becomes infected. This retrospective study was designed to investigate the bacteriology and outcome predictors of SBE in cirrhotic patients.
Medical records of cirrhotic patients treated in a tertiary care university hospital from December 2004 to December 2008 were retrospectively reviewed.
Of 3390 cirrhotic patients seen during the study period, 81 cases of SBE were diagnosed. The incidence of SBE was 2.4% (81/3390) in cirrhotic patients and 16% (81/508) in patients with cirrhosis with hydrothorax. There were 46 monomicrobial infections found in 46 SBE patients. Aerobic Gram-negative organisms were the predominant pathogens (n=29, 63%), and Escherichia coli (n=9, 20%) was the most frequently isolated sole pathogen. The mortality rate of SBE was 38% (31/81). Univariate analysis showed that Child-Pugh score, model for end-stage liver disease (MELD)-Na score, concomitant bacteraemia, concomitant spontaneous bacterial peritonitis, initial intensive care unit (ICU) admission and initial antibiotic treatment failure were predictors of poor outcomes. Multivariate regression analysis demonstrated that the independent factors related to a poor outcome were initial ICU admission [odds ratio (OR): 4.318; 95% confidence interval 1CI) 1.09-17.03; P=0.037], MELD-Na score (OR: 1.267; 95% CI 1.08-1.49; P=0.004) and initial antibiotic treatment failure (OR: 13.10; 95% CI 2.60-66.03).
Spontaneous bacterial empyema in cirrhotic patients is a high mortality complication. The independent factors related to poor outcome are high MELD-Na score, initial ICU admission and initial antibiotic treatment failure. High MELD-Na score may be a useful mortality predictor of SBE in cirrhotic patients.
自发性细菌性脓胸(SBE)是肝硬化患者的一种并发症,其中先前存在的胸腔积液发生感染。本回顾性研究旨在调查肝硬化患者 SBE 的细菌学和预后预测因素。
回顾性分析 2004 年 12 月至 2008 年 12 月在一家三级护理大学医院治疗的肝硬化患者的病历。
在研究期间,3390 例肝硬化患者中诊断出 81 例 SBE。肝硬化患者 SBE 的发生率为 2.4%(81/3390),肝硬化伴胸腔积液患者为 16%(81/508)。46 例 SBE 患者中有 46 例为单一微生物感染。需氧革兰氏阴性菌为主要病原体(n=29,63%),最常分离的单一病原体是大肠杆菌(n=9,20%)。SBE 的死亡率为 38%(31/81)。单因素分析显示,Child-Pugh 评分、终末期肝病模型(MELD)-Na 评分、合并菌血症、合并自发性细菌性腹膜炎、初始重症监护病房(ICU)入院和初始抗生素治疗失败是预后不良的预测因素。多因素回归分析表明,与预后不良相关的独立因素是初始 ICU 入院[比值比(OR):4.318;95%置信区间 1CI 1.09-17.03;P=0.037]、MELD-Na 评分(OR:1.267;95%CI 1.08-1.49;P=0.004)和初始抗生素治疗失败(OR:13.10;95%CI 2.60-66.03)。
肝硬化患者的自发性细菌性脓胸是一种高死亡率并发症。与预后不良相关的独立因素是高 MELD-Na 评分、初始 ICU 入院和初始抗生素治疗失败。高 MELD-Na 评分可能是肝硬化患者 SBE 死亡率的有用预测指标。